NORMAL MITOGEN-INDUCED SUPPRESSION OF THE INTERLEUKIN-6 (IL-6) RESPONSE AND ITS DEFICIENCY IN SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:11
|
作者
WARRINGTON, RJ
RUTHERFORD, WJ
机构
[1] UNIV MANITOBA,DEPT MED,WINNIPEG R3A 1M4,MANITOBA,CANADA
[2] UNIV MANITOBA,DEPT IMMUNOL,WINNIPEG R3A 1M4,MANITOBA,CANADA
关键词
interleukin-6 (IL-6); suppression; Systemic lupus erythematosus (SLE);
D O I
10.1007/BF00917498
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A low-frequency suppressor-cell population in normal peripheral blood inhibits the B-cell CESS response to IL-6, following pokeweed mitogen stimulation. The suppression of IL-6 responsiveness is (i) radiation sensitive, (ii) directed against CESS targets and not mediated by inhibition of IL-6 production, and (iii) associated with nonspecific cytotoxic activity against CESS targets. The generation of these cytolytic cells is also radiation sensitive. A correlation was found between PWM-induced cytotoxicity against CESS and the suppression of IL-6-dependent IgG production. But cytotoxicity toward CESS targets is not responsible for this suppression because (i) IL-2 induces equivalent or greater nonspecific cytotoxicity against CESS in the total absence of suppression of CESS-derived IgG production and (ii) suppression is also induced by mitogen-activated PBL separated from CESS targets by a cell-impermeable membrane. This suppression was not mediated by TNFα/β or IFN-γ. In systemic lupus erythematosus, suppression of IL-6-dependent IgG production is impaired in patients with active disease (29.2±13.7%) compared to patients with inactive disease (70±19.5%) or normal controls (82.8±9.2%). There is also a defect in mitogen-induced nonspecific cytotoxicity in active SLE (specific lysis 15.1±3.5%, compared to 34±4% in normals). Pokeweed mitogen-activated PBL can therefore normally induce suppression of B-cell IL-6 responses and this response is deficient in lupus. © 1990 Plenum Publishing Corporation.
引用
收藏
页码:52 / 60
页数:9
相关论文
共 50 条
  • [1] INTERLEUKIN-6 (IL-6) AND ACUTE PHASE PROTEINS IN THE DISEASE COURSE OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    SWAAK, AJG
    VANROOYEN, A
    AARDEN, LA
    RHEUMATOLOGY INTERNATIONAL, 1989, 8 (06) : 263 - 268
  • [2] ANTI-INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    EVANS, M
    ABDOU, NI
    LUPUS, 1994, 3 (03) : 161 - 166
  • [3] SERUM INTERLEUKIN-6 (IL-6) AND PROLACTIN (PRL) DO NOT CORRELATE WITH DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    DAVIS, WE
    QUINET, R
    WINTERS, E
    COOPER, ES
    CHAMBERS, R
    SEREBRO, L
    WAXMAN, J
    ARTHRITIS AND RHEUMATISM, 1995, 38 (06): : R26 - R26
  • [4] IL-6 GENE POLYMORPHISMS IN SLE (SYSTEMIC LUPUS-ERYTHEMATOSUS)
    LINKERISRAELI, M
    PREHN, J
    LI, L
    WALLACE, D
    KLINENBERG, JR
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A50 - A50
  • [5] NOVEL POLYMORPHISMS OF THE IL-6 GENE IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    LINKERISRAELI, M
    PREHN, J
    WALLACE, DJ
    LI, L
    TOYODA, H
    KLINENBERG, JR
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S175 - S175
  • [6] NOVEL POLYMORPHISMS OF THE IL-6 GENE IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    LINKERISRAELI, M
    PREHN, J
    WALLACE, D
    LI, L
    TOYODA, H
    CHEN, T
    KLINENBERG, JR
    FASEB JOURNAL, 1992, 6 (04): : A1406 - A1406
  • [7] ENHANCED URINARY INTERLEUKIN-6 (IL-6) AND INTERLEUKIN-1-BETA (IL-1-BETA) PARALLEL RENAL-DISEASE ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    GOTTI, E
    CASIRAGHI, F
    NORIS, M
    BENIGNI, A
    REMUZZI, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 749 - 749
  • [8] Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus
    Nepal, Desh
    Gazeley, David
    RHEUMATOLOGY, 2023, 62 (12) : 3804 - 3810
  • [9] Interleukin-6 promotes systemic lupus erythematosus progression with Treg suppression approach in a murine systemic lupus erythematosus model
    Xiaoli Mao
    Yunyun Wu
    Huitian Diao
    Jianlei Hao
    Gaofei Tian
    Zhenghu Jia
    Zheng Li
    Sidong Xiong
    Zhenzhou Wu
    Puyue Wang
    Liqing Zhao
    Zhinan Yin
    Clinical Rheumatology, 2014, 33 : 1585 - 1593
  • [10] Interleukin-6 promotes systemic lupus erythematosus progression with Treg suppression approach in a murine systemic lupus erythematosus model
    Mao, Xiaoli
    Wu, Yunyun
    Diao, Huitian
    Hao, Jianlei
    Tian, Gaofei
    Jia, Zhenghu
    Li, Zheng
    Xiong, Sidong
    Wu, Zhenzhou
    Wang, Puyue
    Zhao, Liqing
    Yin, Zhinan
    CLINICAL RHEUMATOLOGY, 2014, 33 (11) : 1585 - 1593